Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) has acquired a microelectromechanical systems (MEMS) foundry outside Dallas. Completed through a wholly owned subsidiary, Precision BioMEMS Corporation, the acquisition brings the company’s supply chain in-house and establishes Precision as a leading-edge U.S.

大脑-计算机接口（BCI）公司Precision Neuroscience Corporation（Precision）收购了达拉斯郊外的一家微机电系统（MEMS）铸造厂。通过全资子公司Precision BioMEMS Corporation完成的收购，使公司的供应链内部化，并使Precision成为美国领先的公司。

biomedical MEMS manufacturer..

生物医学MEMS制造商。。

The facility comprises a 22,000-square-foot building, including a 5,500-square-foot ISO class 5 clean room (a low-particle zone for manufacturing), more than 500 square feet of ISO class 6 post-processing and assembly space, and more than 50 specialized tools. Precision BioMEMS retained the facility’s team, which has deep expertise in both biomedical and general-purpose MEMS manufacturing.

该设施包括一座22000平方英尺的建筑，包括一个5500平方英尺的ISO 5级洁净室（用于制造的低颗粒区），500多平方英尺的ISO 6级后处理和装配空间，以及50多个专用工具。Precision BioMEMS保留了该设施的团队，该团队在生物医学和通用MEMS制造方面拥有丰富的专业知识。

In addition to its work for Precision, Precision BioMEMS will continue to operate as a foundry serving other U.S. companies..

除了致力于精密加工外，Precision BioMEMS还将继续作为铸造厂为其他美国公司提供服务。。

In addition, the company disclosed that its brain-computer interface system has been awarded U.S. Food and Drug Administration Breakthrough Device designation. Such designation expedites the review of new technologies designed to treat debilitating or life-threatening conditions.

此外，该公司透露，其大脑-计算机接口系统已获得美国食品和药物管理局突破性设备称号。这种指定加速了对旨在治疗衰弱或危及生命的疾病的新技术的审查。

Founded in 2021 by a team including neurosurgeon Benjamin Rapoport and business leader Michael Mager, Precision has created a direct communication pathway between the human brain and computers. The company completed first-in-human clinical studies of its device in April, mapping the human brain’s activity at an unprecedented level of detail.

由神经外科医生本杰明·拉波波特（BenjaminRapoport）和商业领袖迈克尔·马格（MichaelMager）组成的团队于2021年成立，Precision已经在人脑和计算机之间建立了一条直接的通信途径。该公司于4月完成了其设备的首次人体临床研究，以前所未有的细节绘制了人脑活动图。

In coming years, Precision expects its minimally invasive brain implant to enable people with severe neurological conditions such as speech deficits and paralysis to regain independence, communicate with loved ones, and rejoin the workforce. The foundry acquisition gives Precision full production control of its core technology—a thin-film microelectrode array, called the Layer 7 Cortical Interface, which packs 1,024 electrodes into an area spanning 1.5 square centimeters—enabling a greater degree of quality management and the ability to iterate rapidly on future versions. .

在未来几年，Precision预计其微创脑部植入物将使患有严重神经系统疾病（如言语缺陷和瘫痪）的人恢复独立，与亲人沟通，并重新加入工作队伍。foundry的收购为其核心技术提供了精确的全面生产控制，这是一种薄膜微电极阵列，称为第7层皮层界面，它将1024个电极封装在1.5平方厘米的区域内，从而实现更大程度的质量管理，并能够在未来的版本上快速迭代。。。

“To deliver brain–computer interface technology to the millions of people who stand to benefit, we need to rethink the medical device supply chain,” said Mager, Precision’s CEO. “High precision microfabrication is critical to building powerful brain–computer interfaces, and it will play an increasingly important role in medical device manufacturing going forward.

Precision首席执行官Mager表示：“为了向数百万受益的人提供大脑-计算机接口技术，我们需要重新思考医疗设备供应链。”。“高精度微制造对于构建强大的大脑-计算机接口至关重要，它将在未来的医疗器械制造中发挥越来越重要的作用。

Precision BioMEMS will help us build the neural technology of tomorrow while also advancing the broader U.S. medical device industry.” .

Precision BioMEMS将帮助我们构建未来的神经技术，同时也将推动更广泛的美国医疗器械行业。”。。

Precision’s brain–computer interface is an investigational device and is not available for sale in the United States.

Precision的大脑-计算机接口是一种研究设备，在美国不可销售。

Precision Neuroscience is working to provide breakthrough treatments for neurological illnesses. The company is building the only brain–computer interface designed to be minimally invasive, safely removable, and capable of processing large amounts of data.

精准神经科学（Precision Neuroscience）正致力于为神经疾病提供突破性的治疗方法。该公司正在构建唯一一个微创、安全可移动且能够处理大量数据的大脑-计算机接口。